Wells Fargo’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,800
Closed -$269K 7353
2025
Q4
$269K Sell
2,800
-43,500
-94% -$4.23M ﹤0.01% 4900
2025
Q3
$4.41M Sell
46,300
-11,800
-20% -$1.08M ﹤0.01% 2689
2025
Q2
$5.06M Buy
+58,100
New +$4.93M ﹤0.01% 2460
2025
Q1
Sell
-22,200
Closed -$1.77M 7167
2024
Q4
$1.77M Hold
22,200
﹤0.01% 3285
2024
Q3
$2M Buy
+22,200
New +$1.87M ﹤0.01% 3053
2023
Q4
Sell
-22,200
Closed -$1.74M 7671
2023
Q3
$1.74M Buy
+22,200
New +$1.86M ﹤0.01% 2914
2020
Q1
Sell
-137,200
Closed -$65K 6562
2019
Q4
$65K Buy
+137,200
New +$15.1M ﹤0.01% 5434

Other funds holding MDT

Wells Fargo's MDT Position: Q1 2026 in Review

Wells Fargo increased its Medtronic (MDT) stake by 6.8% in Q1 2026, buying an estimated $45.5M and bringing the position to 7,514,778 shares worth $651M. The position accounts for 0.12% of the portfolio, ranked #161.

Wells Fargo first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.85B in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Wells Fargo held 7,514,778 shares of Medtronic worth $651M as of Q1 2026.
  • Wells Fargo bought 475,411 Medtronic shares in Q1 2026, an estimated $45.5M.
  • Medtronic made up 0.12% of Wells Fargo's portfolio in Q1 2026, its #161 holding.
  • Wells Fargo first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Medtronic position peaked at $1.85B in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.